drugset / Trial / NCT06617091
A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV.
Phase 1
Recruiting
120 enrolled
International AIDS Vaccine Initiative
Mutala Trust · collabRagon Institute · collabReiThera Srl · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
A Phase 1 Randomized Double Blinded Placebo Controlled, Dose Ranging Trial, of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine (GRAdHIVNE1 Vaccine), Administered to Healthy Adults Living without HIV and Living with HIV, in Southern Africa
Timeline
- Start
- 2025-07-28
- Primary completion
- 2027-03-31
- Completion
- 2027-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GRAdHIVNE1 | Vaccine | 5e+10 vg | — |
| Subject | GRAdHIVNE1 | Vaccine | 2e+11 vg | — |